BenchSci, a leading provider of AI software for biopharma research and development, today announced a renewed two-year contract with Merck, known as MSD outside of the United States and Canada.

Tidewater presents a compelling opportunity after a recent price drop and strong Q3 results. Find out why TDW stock is a Buy.

The Indian fixed income market in 2025 is navigating a complex macroeconomic landscape. While inflation has sharply declined ...

One of Fidesz's main political products and campaign weapons is the reduction of utility costs, but lower bills at the end of ...

Novo Nordisk A/S advances metabolic and rare disease treatments through global research, manufacturing, and clinical ...